Invenire Partners, LP - Q2 2022 holdings

$75.3 Million is the total value of Invenire Partners, LP's 29 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 37.5% .

 Value Shares↓ Weighting
TTEC SellTTEC Holdings Inc$3,440,800,000
-26.6%
50,682
-10.8%
4.57%
-22.3%
CLAR SellClarus Corp$3,362,939,000
-26.2%
177,090
-11.5%
4.47%
-21.9%
CMCO SellColumbus McKinnon Corp$1,946,096,000
-41.6%
68,597
-12.7%
2.58%
-38.2%
NDLS SellNoodles & Co$902,179,000
-42.6%
191,953
-27.1%
1.20%
-39.2%
ASPN SellAspen Aerogels Inc$242,000,000
-87.8%
24,494
-57.4%
0.32%
-87.1%
LLNW ExitLimelight Networks Inc$0-165,000
-100.0%
-1.08%
ASUR ExitAsure Software Inc$0-259,524
-100.0%
-1.94%
UTI ExitUniversal Technical Institute Inc$0-300,238
-100.0%
-3.33%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DHI Group Inc4Q3 20227.9%
Tetra Technologies Inc4Q3 20226.5%
Harrow Health Inc4Q3 20228.4%
TTEC Holdings Inc4Q3 20225.9%
Clarus Corp4Q3 20225.9%
Apyx Medical Corp4Q3 20226.5%
InfuSystem Holdings Inc4Q3 20225.1%
PAR Technology Corp4Q3 20224.9%
Cantaloupe Inc4Q3 20225.2%
Marcus Corp4Q3 20224.4%

View Invenire Partners, LP's complete holdings history.

Latest filings
TypeFiled
SC 13G/A2023-03-31
SC 13G2023-01-23
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-13
13F-HR2022-02-14
D/A2019-03-12
D2018-01-02

View Invenire Partners, LP's complete filings history.

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (75305000.0 != 75305603000.0)

Export Invenire Partners, LP's holdings